QYNAPSE will present results on QyPredict®, an AI prediction technology for patient selection in Alzheimer’s clinical trials, at the 13th Clinical Trials on Alzheimer’s Disease (CTAD) Conference. The software computes a cognitive decline risk score that can be used to enrich patient selection strategy with the aim to increase clinical trial success probability.
Qynapse is excited to participate in MSVirtual2020 to share and discuss innovative and cutting-edge research in the field of Multiple Sclerosis (MS). The latest QyScore® validation and performance advances will be presented during the conference.
Qynapse is thrilled to be part of the Scientific Program of AAIC and the Virtual Exhibition from July 27 to July 31 − to present our latest advances and solutions.
From July 14 – 18th, Qynapse will be part of the 2019 Alzheimer’s Association International Conference® (AAIC®) held in Los Angeles, California
Qynapse took part in the 2019 International Conference on Alzheimer’s & Parkinson’s Disease (AD/PDTM) in Lisbon, Portugal from March 26 – 31st
From July 22– 26th, Qynapse took part in the 2018 Alzheimer’s Association International Conference® (AAIC®) held in Chicago, Illinois
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
- Qynapse wishes you a Happy New Year 2021! We look forward to continue with exciting collaborations this year – to d… https://t.co/fMjDxQFUq817 days ago
- By advancing #decentralizedtrials we can make clinical trials more patient-focused, diverse and efficient, and leve… https://t.co/z8ck93CH7Y22 days ago
- The Virtual Exhibition of the 106th RSNA Annual Meeting #RSNA20 is now Live! We look forward to welcoming you on ou… https://t.co/rCqniwCcBD53 days ago
- QYNAPSE is pleased to sponsor the 106th RSNA Annual Meeting #RSNA20 – we look forward to engaging with the internat… https://t.co/3CWXyHCCJL58 days ago
130, rue de Lourmel
75015 Paris – France